Literature DB >> 30425767

Which Nutritional Factors Are Good for HDL?

Hidekatsu Yanai1, Norio Tada2.   

Abstract

Entities:  

Year:  2018        PMID: 30425767      PMCID: PMC6225857          DOI: 10.14740/jocmr3646

Source DB:  PubMed          Journal:  J Clin Med Res        ISSN: 1918-3003


× No keyword cloud information.

To the Editor

High-density lipoprotein (HDL) is a lipoprotein which has anti-atherogenic property by reversing cholesterol transport from the peripheral tissues to liver. Low HDL-cholesterol (HDL-C) as well as high LDL-C is associated with the development of coronary heart diseases [1, 2]. Low HDL-C is commonly observed in patients with insulin resistance, obesity and type 2 diabetes. In our previous study [3], serum HDL-C in type 2 diabetes [4], especially in type 2 diabetic patients with obesity [5], was lower than young lean men [6] and low Framingham risk score subjects [7] (Fig. 1), suggesting a significant influence of obesity, type 2 diabetes and insulin resistance on serum HDL-C levels.
Figure 1

Serum HDL-C levels in young men, middle-aged people with low Framingham risk score, type 2 diabetic patients without obesity and type 2 diabetic patients with obesity. This figure was made by modification of data in our previous report [3].

Serum HDL-C levels in young men, middle-aged people with low Framingham risk score, type 2 diabetic patients without obesity and type 2 diabetic patients with obesity. This figure was made by modification of data in our previous report [3]. Abnormal lipid metabolism induced by obesity, insulin resistance and type 2 diabetes was shown in Figure 2. Insulin resistance increases activity and expression of hormone-sensitive lipase (HSL) in adipose tissue, which catalyzes the breakdown of triglyceride (TG), releasing free fatty acids (FFAs) (Fig. 2) [8]. Increased FFA entry to liver elevates hepatic production of very low-density lipoprotein (VLDL) which is a TG-rich lipoprotein. Insulin resistance also decreases the activity of lipoprotein lipase (LPL), the rate-limiting enzyme of the catabolism of TG-rich lipoproteins such as VLDL [9]. The formation of HDL is related with the catabolism of TG-rich lipoproteins by LPL [10]. Therefore, reduced LPL activity increases VLDL and reduces HDL.
Figure 2

Abnormal lipid metabolism induced by obesity, insulin resistance and type 2 diabetes. FFA: free fatty acid; gLDL: glycated LDL: HSL: hormone-sensitive lipase; LDL-R: LDL-receptor; LPL: lipoprotein lipase; NPC1L1: Niemann-Pick C1-like 1; oLDL: oxidized LDL; sdLDL: small dense LDL; VLDL: very low-density lipoprotein.

Abnormal lipid metabolism induced by obesity, insulin resistance and type 2 diabetes. FFA: free fatty acid; gLDL: glycated LDL: HSL: hormone-sensitive lipase; LDL-R: LDL-receptor; LPL: lipoprotein lipase; NPC1L1: Niemann-Pick C1-like 1; oLDL: oxidized LDL; sdLDL: small dense LDL; VLDL: very low-density lipoprotein. Insulin resistance is associated with diminished LDL-receptor (LDL-R) [11], and intestinal mRNA expression of Niemann-Pick C1-like 1 (NPC1L1) protein is increased in diabetes [12], suggesting that insulin resistance and diabetes may increase serum LDL-C by reducing clearance and enhancing cholesterol absorption. The dietary and nutritional factors could influence on HDL metabolism. To make “Dietary Reference Intake for Japanese 2020 (for low HDL-C)”, we searched meta-analyses of randomized controlled trials (RCTs) which investigated effects of energy and carbohydrate intake [13], glycemic index and intake of dietary fiber [14], intake of soy and non-soy legume [15] and consumption of various fatty acids [16], on serum HDL-C levels. Seen in Figure 2, since low HDL-C is likely to accompany with obesity, insulin resistance and high TG. Elevation of LDL-C can accompany with low HDL-C; moreover, atherogenic properties of LDL such as small dense LDL, oxidized LDL and glycated LDL are observed in type 2 diabetes [17]. Therefore, we investigated effects of nutritional factors on metabolic parameters other than HDL-C such as LDL-C, TG, body weight and waist circumference. The summary of effects of nutritional factors on HDL-C and other metabolic parameters was shown in Table 1. Low carbohydrate diet increased HDL-C and decreased TG, however, increased LDL-C. Dietary fiber consumption did not affect HDL-C and TG, however, reduced LDL-C. Soy consumption increased HDL-C and deceased both TG and LDL-C. Saturated fatty acid consumption increased HDL-C, however, also increased LDL-C. Industrially produced trans fatty acid consumption reduced HDL-C and increased LDL-C.
Table 1

Effects of Nutritional Factors on HDL-C and Other Metabolic Parameters

HDL-CLDL-CTGBW, BMI, WC
Carbohydrate consumption
  Low LC diets (versus LF diets)
  Low LC diets↓ or →
  Low GI diets↑ or →↓ or →↓ or →BW → or BMI → or WC →
  Free sugars
  Fructose (hypercaloric)
  Fructose (isocaloric)→ or ↑
Dietary fiber consumption
  Konjac glucomannan
  Beta-glucan
  Increased dietary fiber intake↑ or →
  Whole-grain foods
  PolyglycoplexBW →
  Barley
  Psyllium
Soy and non-soy legume consumption
  Soy
  Soy products
  Soy protein
Fatty acids consumption
  SFA
  Industrially produced-TFA
  Ruminant-TFA
  CLA
  n-3 PUFA→ or ↑→ or ↓WC ↓ BMI →
  MUFA→ or ↑↓ or →→ or ↓BW ↓ or BMI →

BMI: body mass index; BW: body weight; CLA: conjugated linoleic acid; GI: glycemic index; HDL-C: high-density lipoprotein-cholesterol; LC: low carbohydrate; LDL-C: low-density lipoprotein-cholesterol; LF: low fat; MUFA: mono-unsaturated fatty acid; PUFA: poly-unsaturated fatty acid; SFA: saturated fatty acid; TFA: trans fatty acid; TG: triglyceride; WC: waist circumference.

BMI: body mass index; BW: body weight; CLA: conjugated linoleic acid; GI: glycemic index; HDL-C: high-density lipoprotein-cholesterol; LC: low carbohydrate; LDL-C: low-density lipoprotein-cholesterol; LF: low fat; MUFA: mono-unsaturated fatty acid; PUFA: poly-unsaturated fatty acid; SFA: saturated fatty acid; TFA: trans fatty acid; TG: triglyceride; WC: waist circumference. When we consider effects of nutritional factors on HDL-C to prevent atherosclerosis, we should think about effects of nutritional factors on other lipids, especially LDL-C.
  12 in total

1.  Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man.

Authors:  E A Nikkilä; M R Taskinen; M Kekki
Journal:  Atherosclerosis       Date:  1978-04       Impact factor: 5.162

2.  Understanding of Diabetic Dyslipidemia by Using the Anion-Exchange High Performance Liquid Chromatography Data.

Authors:  Hidekatsu Yanai; Yuji Hirowatari; Kumie Ito; Hideo Kurosawa; Norio Tada; Hiroshi Yoshida
Journal:  J Clin Med Res       Date:  2016-03-20

3.  Relevance of intermediate-density lipoprotein cholesterol to Framingham risk score of coronary heart disease in middle-aged men with increased non-HDL cholesterol.

Authors:  Kumie Ito; Hiroshi Yoshida; Hidekatsu Yanai; Hideo Kurosawa; Ryo Sato; Daisuke Manita; Yuji Hirowatari; Norio Tada
Journal:  Int J Cardiol       Date:  2013-07-11       Impact factor: 4.164

4.  Estimation of lipoprotein profile in patients with type II diabetes and its relevance to remnant lipoprotein cholesterol levels.

Authors:  Hiroshi Yoshida; Yuji Hirowatari; Hideo Kurosawa; Daisuke Manita; Hidekatsu Yanai; Kumie Ito; Norio Tada
Journal:  Atherosclerosis       Date:  2012-03-30       Impact factor: 5.162

5.  Regulation of hormone-sensitive lipase in streptozotocin-induced diabetic rats.

Authors:  C Sztalryd; F B Kraemer
Journal:  Metabolism       Date:  1995-11       Impact factor: 8.694

6.  High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men.

Authors:  A Kitamura; H Iso; Y Naito; M Iida; M Konishi; A R Folsom; S Sato; M Kiyama; M Nakamura; T Sankai
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

Review 7.  The intestine as a regulator of cholesterol homeostasis in diabetes.

Authors:  Gerald H Tomkin
Journal:  Atheroscler Suppl       Date:  2008-08-06       Impact factor: 3.235

8.  HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.

Authors:  Christian K Roberts; Kaihui Liang; R James Barnard; Choong H Kim; Nosratola D Vaziri
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

9.  Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.

Authors:  E A Nikkilä; J K Huttunen; C Ehnholm
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

10.  Effects of diacylglycerol on glucose, lipid metabolism, and plasma serotonin levels in lean Japanese.

Authors:  Hidekatsu Yanai; Hiroshi Yoshida; Yoshiharu Tomono; Yuji Hirowatari; Hideo Kurosawa; Akiyo Matsumoto; Norio Tada
Journal:  Obesity (Silver Spring)       Date:  2008-01       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.